Mantell Associates

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the first therapy of its kind for the rare disease and making Italy’s Fondazione Telethon the first nonprofit to usher a gene therapy across the regulatory finish line in the U.S. Read more below: https://lnkd.in/e3_92nvT #pharmanews #fda #genetherapy

Quotient Sciences, a global drug development, research and manufacturing accelerator, and Intrepid Labs, an AI leader in pharmaceutical formulation science, have announced a multi-year strategic partnership to advance the use of artificial intelligence (AI) in early drug development. Read more below: https://lnkd.in/euuvzbnx #pharmanews #drugdevelopment #ai

Don't just listen to us, listen to what our clients and candidates have to say... "Millie made the whole recruiting process easy. Clear communication, fast turnaround, and genuinely helpful. Highly recommend working with her." Get in touch with Millie Bone to discuss your next career move, or to grow your current team! #testimonialtuesday #testimonial #cdmorecruitment

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for immuno-dermatology conditions. Read more below: https://lnkd.in/egjzdtSz #biotechnews #ai #biotech

Today we are pleased to welcome Page Punshon to the Mantell Associates team! Page brings previous recruitment experience, and has joined our CDMO team led by Vincent Mackay. She will be specialising in Engineering and Technical Operations within the Cell & Gene Therapy space. Welcome Page - we look forward to your success here at MA! #recruitmentlondon #cdmorecruitment #cellandgenetherapy

Natera is looking to grow its portfolio of tools to detect the recurrence of cancer with a deal to acquire Foresight Diagnostics, the Stanford University spinout and developer of blood tests for tracking minimal residual disease, or MRD. Read more below: https://lnkd.in/efXDmQxP #biotechnews #diagnostics #moleculardiagnostics

Pfizer’s VC arm has backed a $100 million series A raise for OTR Therapeutics as the Chinese biotech tacks on preclinical neurological assets to its varied portfolio. Read more below: https://lnkd.in/gPy2ir2K #biotechnews #biotech #pharmafunding

Mantell Associates is currently partnered with a small-mid sized Oncology & Pathology organisation, headquartered out of the United States, who are searching for a new VP of Commercial to completely reshape their strategy and commercial roadmap. Apply for this role online - https://lnkd.in/eQdPyDrt - or contact Robin Mantell on +44 (0)20 3854 7700. #commercialjobs #oncologyjobs #vpjobs

As 2025 draws to a close, Saudi Arabia’s market access landscape looks very different from just a few years ago. Jude Mockridge explores how market access - what used to be driven mainly by external reference pricing and tendering - is rapidly evolving into a value-based, evidence-led environment aligned with Vision 2030 and the Health Sector Transformation Program. Read more below: https://lnkd.in/eUPyDXyJ #saudiarabia #marketaccess #saudipharma

Thermo Fisher Scientific is expanding its bioprocessing capabilities across Asia with a new Bioprocess Design Center in Hyderabad, India, and expanded Bioprocess Design Centers in Incheon, Korea and Singapore. Read more below: https://lnkd.in/eh7k8Rp8 #pharmanews #bioprocessing #pharmaasia